Treatment of castration-induced menopausal symptoms with low dose diethylstilbestrol in men with advanced prostate cancer

Jeffrey I. Miller, Frederick R. Ahmann

Research output: Contribution to journalArticle

43 Scopus citations

Abstract

Menopausal symptoms manifesting as hot flashes and sweats occur in up to 75 percent of patients following either orchiectomy or treatment with a luteinizing hormone-releasing hormone agonist for prostate cancer. As many as one third of these patients will experience symptoms severe enough to seek palliation. We treated 12 such patients with low dose diethylstilbestrol (1/3 mg daily). Nine patients demonstrated both objective and subjective improvement in their menopausal symptoms. Five patients experienced toxicity including new onset of gynecomastia or breast soreness although no patient discontinued treatment on this basis. No cardiovascular complications were noted. We conclude that low dose diethylstilbestrol is an inexpensive, effective means of controlling troublesome postorchiectomy menopausal symptoms in carefully selected patients.

Original languageEnglish (US)
Pages (from-to)499-502
Number of pages4
JournalUrology
Volume40
Issue number6
DOIs
StatePublished - Dec 1992

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Treatment of castration-induced menopausal symptoms with low dose diethylstilbestrol in men with advanced prostate cancer'. Together they form a unique fingerprint.

  • Cite this